Novel Arylsulfonylhydrazones as Breast Anticancer Agents Discovered by Quantitative Structure-Activity Relationships

Breast cancer (BC) is the second leading cause of cancer death in women, with more than 600,000 deaths annually. Despite the progress that has been made in early diagnosis and treatment of this disease, there is still a significant need for more effective drugs with fewer side effects. In the presen...

Descripción completa

Detalles Bibliográficos
Autores principales: Angelova, Violina T., Tatarova, Teodora, Mihaylova, Rositsa, Vassilev, Nikolay, Petrov, Boris, Zhivkova, Zvetanka, Doytchinova, Irini
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10004090/
https://www.ncbi.nlm.nih.gov/pubmed/36903304
http://dx.doi.org/10.3390/molecules28052058

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10004090/
https://www.ncbi.nlm.nih.gov/pubmed/36903304
http://dx.doi.org/10.3390/molecules28052058

Ejemplares similares